KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Long-Term Debt Repayments (2018 - 2025)

Historic Long-Term Debt Repayments for Cme (CME) over the last 9 years, with Q1 2025 value amounting to $750.0 million.

  • Cme's Long-Term Debt Repayments changed N/A to $750.0 million in Q1 2025 from the same period last year, while for Sep 2025 it was $750.0 million, marking a year-over-year change of. This contributed to the annual value of $16.4 million for FY2023, which is 9783.13% down from last year.
  • According to the latest figures from Q1 2025, Cme's Long-Term Debt Repayments is $750.0 million.
  • In the past 5 years, Cme's Long-Term Debt Repayments ranged from a high of $756.1 million in Q1 2022 and a low of $100000.0 during Q2 2022
  • In the last 3 years, Cme's Long-Term Debt Repayments had a median value of $383.2 million in 2023 and averaged $380.6 million.
  • Over the last 5 years, Cme's Long-Term Debt Repayments had its largest YoY gain of 1630000.0% in 2023, and its largest YoY loss of 1630000.0% in 2023.
  • Quarter analysis of 3 years shows Cme's Long-Term Debt Repayments stood at $100000.0 in 2022, then surged by 16300.0% to $16.4 million in 2023, then skyrocketed by 4473.17% to $750.0 million in 2025.
  • Its Long-Term Debt Repayments was $750.0 million in Q1 2025, compared to $16.4 million in Q2 2023 and $100000.0 in Q2 2022.